Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23499)

• Formulation Name: Oxybutynin 5mg extended release tablet
• Company: Janssen Pharms

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Oxybutynine	(DMJPBAX)	Obsolete neurogenic bladder		Investigative

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Cellulose acetate	(E00702)	Not Available	Coating agent; Modified-release agent; Diluent
Haematite red	(E00236)	14833	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 4000	(E00654)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent